{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2005"],"condition":["Sarcoma","Carcinoma, Non-Small-Cell Lung","Lung cancer","Colorectal cancer","Mesothelioma","Breast cancer","Bladder cancer","Neoplasms","Ovarian cancer","Thyroid cancer","Esophageal Neoplasms","Advanced Solid tumor","Head and neck cancer","Tumor","Lung neoplasms"],"disease":["Lung Cancer","Sarcoma","Colorectal Cancer","Mesothelioma","Bladder Cancer","Breast Cancer","Lung Neoplasms","Neoplasms","Ovarian Cancer","Esophageal Neoplasms","Thyroid Cancer","Advanced Solid Tumor","Tumor","Carcinoma, Non-small-cell Lung","Head And Neck Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2035464"],"location":["United States"],"study_start_month":["9"],"keyword":["Chondrosarcoma","Thyroid Neoplasms","Bladder neoplasms","Fibrosarcoma","PXD101","Mesothelioma, cystic","Coin Lesion, Pulmonary","Osteosarcoma","Carcinoma, Small Cell","Belinostat","Myosarcoma","Pulmonary Sclerosing Hemangioma","Facial Neoplasms","Adenosarcoma","Phyllodes Tumor","Fluorouracil","Myxosarcoma","Carcinoma, Bronchogenic","Parathyroid Neoplasms","Carcinosarcoma","Hemangiosarcoma","Otorhinolaryngologic Neoplasms","Histiocytoma, Malignant Fibrous","Mouth Neoplasms","Pancoast’s Syndrome","Mixed Tumor, Mesodermal","Lymphangiosarcoma","Liposarcoma","Leiomyosarcoma","Kidney cancer","Androgen-independent prostate cancer","Tracheal Neoplasms"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors","description":"This is a study to assess the combination of PXD101 and 5-Fluorouracil (5-FU)in patients with advanced solid tumors. The primary goal of the study is to understand the safety, anti-tumor activity, and how the study drug behaves within the body when given with 5-Fluorouracil (5-FU).","dates":{"creation":"2005-09-15"},"accession":"2035464","cross_references":{"ClinicalTrials___gov":["NCT00413322"]}}